Hoffman LaRoche Rebuffed Call to Monitor Accutane Users – USA Today

Hoffman LaRoche Rebuffed Call to Monitor Accutane Users – USA Today Tue, 7 Dec 2004 An investigative cover story in USA Today – Drugmaker Rebuffed Call to Monitor Users–affirms the indispensable role of litigation in bringing the facts about adverse drug effects to public knowledge. Lawsuits against Hoffman-La Roche, manufacturer…

UK Pharma Association Displaying Acute Anxiety / FDA approves Focalin XR for ADHD

UK Pharma Association Displaying Acute Anxiety / FDA approves Focalin XR for ADHD Tue, 14 Jun 2005 The good news is that British physicians are taking a more cautious approach and cutting down on their prescribing of drugs whose adverse side effects often do more harm than good. But the…

Despite Accutane Suicide Risk, Judge Refuses to make company Memos Public

Despite Accutane Suicide Risk, Judge Refuses to make company Memos Public Mon, 31 Jan 2005 Judge James Moody, A federal judge in Tampa, Florida, ruled against plaintiff lawyers who sought to share internal documents belonging to Hoffman-LaRoche that show the company knew about the increased suicide risk associated with the…